PMH38 A COST UTILITY ANALYSIS OF FIRST LINE ANTIPSYCHOTICS FOR THE PREVENTION OF SCHIZOPHRENIA RELAPSE IN THE UNITED KINGDOM
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72915-1
https://www.valueinhealthjournal.com/article/S1098-3015(11)72915-1/fulltext
Title :
PMH38 A COST UTILITY ANALYSIS OF FIRST LINE ANTIPSYCHOTICS FOR THE PREVENTION OF SCHIZOPHRENIA RELAPSE IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72915-1&doi=10.1016/S1098-3015(11)72915-1
First page :
A452
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1071